$RPD

Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know

After July Producer Price Index came in flat month over month, below expectations, and earlier CPI showed 0.1% monthly growth with annual inflation cooling to 3.4%, several software stocks rose. The article cites Rapid7 (RPD) up 3.6%, Tenable (TENB) up 3.2%, Marqeta (MQ) up 1.1%, Doximity (DOCS) up 0.3%, and 8x8 (EGHT) up 0.2%.

Original reporting
Published Aug 16, 2026, 7:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 16, 2026, 7:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know — source image
Decision brief

The 30-second read

$RPDBullishMed
01

Why it matters

It argues that lower inflation reduces bond yields and increases the present value of long-duration software cash flows, leading to multiple expansion across the sector.

02

Market read

A macro release (July PPI) is presented as the driver of same-day upside across multiple long-duration software names.

03

What to watch

The text does not discuss whether yields actually fell on the day, nor does it provide consensus expectations beyond PPI; sector moves could be partially driven by positioning/technical factors.

Relevance 5/10Novelty 4/10Timing: afternoon session reaction to July PPI being flat month-over-month

Background

The piece ties a broad afternoon rally in software/data analytics names to July PPI coming in flat and CPI cooling, implying less hawkish Fed pricing.

Company-level read

Ticker impact

$RPDBullishMedium confidence
Context

Rapid7 shares jumped 3.6% in the afternoon after July PPI came in flat, supporting a lower-rate discount-rate narrative for software.

Expected impact

Near-term upside bias likely tied to rates/yields; stock-specific follow-through is uncertain without company catalysts.

Evidence & confidence

The article attributes the sector move to flat PPI and cooling inflation, then only adds generic volatility context for Rapid7 without new company fundamentals.

$EGHTBullishLow confidence
Context

8x8 shares rose 0.2% alongside other software names after July PPI was flat month-over-month, easing discount-rate pressure.

Expected impact

Modest, rate-dependent trading likely; conviction low without additional EGHT-specific news.

Evidence & confidence

The text provides no EGHT-specific catalyst, only that it was among the stocks impacted by the macro print.

$DOCSBullishLow confidence
Context

Doximity shares gained 0.3% after July PPI was reported flat, reinforcing the article’s thesis of multiple expansion for long-duration software.

Expected impact

Short-term performance likely tracks yields; sustained move would require DOCS-specific catalysts not present here.

Evidence & confidence

No new DOCS operational, financial, or regulatory details are disclosed beyond being included in the macro-driven list.

$MQBullishLow confidence
Context

Marqeta shares rose 1.1% in the afternoon after July PPI came in flat, consistent with lower discount rates boosting software/data analytics valuations.

Expected impact

Potential continuation if yields fall further; otherwise mean reversion risk given lack of MQ-specific news.

Evidence & confidence

The only MQ fact is the intraday jump tied to the PPI/CPI narrative.

$TENBBullishMedium confidence
Context

Tenable shares climbed 3.2% after July PPI was flat, which the article says reduces urgency for higher-for-longer rates and lifts software multiples.

Expected impact

Likely to remain correlated with rates; stock-specific upside needs additional catalysts not provided.

Evidence & confidence

The text explicitly frames the move as a response to inflation data and discount-rate math, with no new TENB fundamentals.

Market effects

Supports a software multiple-expansion trade as inflation moderates and discount rates are repriced lower.

Primarily US rates and US-listed software names; no explicit regional spillover beyond the US market wrap framing.

Lower global yields narrative can transmit to long-duration tech/software valuations internationally, though the article is US-focused.

Counterpoint

The article may over-attribute moves to macro math; without company-specific catalysts, gains could fade as traders revert after the initial rates repricing.

Key entities

  • Rapid7

    Vulnerability management stock included in the afternoon jump list.

  • 8x8

    Video conferencing software stock included in the afternoon jump list.

  • Doximity

    Healthcare/life sciences software stock included in the afternoon jump list.

  • Marqeta

    Payments software stock included in the afternoon jump list.

  • Tenable

    Vulnerability management stock included in the afternoon jump list.

Related articles

$RPDHighAI 8/10

Rapid7 (RPD) Bets On A Sharper Focus To Reverse Its Slide

Rapid7 (RPD) reported Q2 earnings with a 1% YoY ARR growth to $824M, driven by 5% YoY growth in detection and response. Profitability beat guidance with non-GAAP operating income of $28.9M. The company cut 12% of its workforce to improve margins. However, total ARR and revenue declined, with Q3 ARR guided down to $812M. Management raised full-year non-GAAP operating income guidance to $129M-$133M. The stock trades at a forward P/E of 6.88.

$RPDMedAI 9/10

Rapid7 (RPD) Q2 2026 Earnings Call Transcript

Rapid7 (RPD) reported Q2 FY2026 total ARR of $824 million, down 2% year over year, and revenue of $210.9 million, down 1.5%. Core platform ARR grew 1% and Detection and Response ARR grew 5%. Non-GAAP operating income was $28.9 million, free cash flow $31.9 million. FY2026 revenue guidance is $837–$841 million.

$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.

$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.